
FOLLOWUS
1. Internal Medical Department, Hospital Affiliated to Shandong University of Traditional Chinese Medicine,Jinan,China
2. Doctorial Graduate Student of Beijing University of Chinese Medicine,Beijing,China,2008
Published:2010,
Published Online:16 May 2010,
Scan for full text
Li, X., Jiang, P. & Fu, Cg. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity., Chin. J. Integr. Med. 16, 138–144 (2010). https://doi.org/10.1007/s11655-010-0138-4
Xiao Li, Ping Jiang, Chang-geng Fu. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity. [J]. Chinese Journal of Integrative Medicine 16(2):138-144(2010)
Li, X., Jiang, P. & Fu, Cg. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity., Chin. J. Integr. Med. 16, 138–144 (2010). https://doi.org/10.1007/s11655-010-0138-4 DOI:
Xiao Li, Ping Jiang, Chang-geng Fu. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity. [J]. Chinese Journal of Integrative Medicine 16(2):138-144(2010) DOI: 10.1007/s11655-010-0138-4.
To observe the difference in fatty degree
glucose-lipid disorder and adipose-hormones between diet induced obesity (DIO) rats and diet induced obesity resistance (DIO-R) rats
and to explore the effect and acting mechanism of Chinese drugs for strengthening Pi (脾
CD-SP) and those for both strengthening Pi and dissolving phlegm (CD-SPDP) in inhibiting obesity. Excepting eight rats allocated in the blank control group
the other 54 rats were fed with high-lipid forage for 12 weeks to establish models of obesity. Finally
30 DIO rats and 8 DIO-R rats (shown by their body weight) were obtained. The DIO rats were divided into three groups
which were given gastric perfusion
respectively
with normal saline (Group A)
CD-SP (Group B)
and CD-SPDP (Group C). Fourteen weeks later
the animals’ body weight (BW)
length (BL)
blood levels of fasting insulin (FIn)
fasting glucose (FBG)
triglyceride (TG)
cholesterol (TC)
leptin (LP)
neuropeptide Y (NPY)
C-reactive protein (CRP)
tumor necrosis factor-α(TNF-α)
adiponectin (AN)
and resistin (RS) were measured; insulin resistance index (IRI) was calculated
and the degree of obesity and lipid content in abdominal cavity of rats were estimated. Moreover
the levels of LP
CRP
TNF-α
AN and RS in homogenate of rats’ adipose tissues (ATH) were determined. After 12 weeks of high-lipid diet
the BW of DIO rats was higher than that of normal or DIO-R rats. After a 14-week continuous high-lipid diet feeding
in DIO rats
BW
lipid coefficient (LC)
and IRI were significantly increased (P<0.01); serum levels of TNF-α
LP and AN were lower
NPY was higher
while the ATH levels of LP and AN were lower and TNF-α was higher in DIO rats than in DIO-R rats (P<0.05 or P<0.01); blood levels of FBG and lipids in DIO rats showed an increasing trend but was statistically insignificant (P>0.05); no significant difference was found in serum levels of CRP and RS due to the overly high data dispersion. Comparisons of the 3 DIO groups showed that BW
body weight index (BWI)
LC and IRI were significantly lowered after treatment (P<0.01) in Group C
while these indexes were not significantly different between Group A and B; the serum levels of TNF-α
LP
and AN increased
NPY decreased in Group B and C
ATH levels of LP and AN increased
and TNF-α decreased in the two groups; but NPY
LP
and AN in blood and ATH were higher in Group C than those in Group B (P<0.05 or P<0.01). CD-SPDP could inhibit DIO and IR
showing that the effect is better than that of CD-SP
and its mechanism is related to promotion of LP and AN secretion and elevation of serum NPY.
To observe the difference in fatty degree
glucose-lipid disorder and adipose-hormones between diet induced obesity (DIO) rats and diet induced obesity resistance (DIO-R) rats
and to explore the effect and acting mechanism of Chinese drugs for strengthening Pi (脾
CD-SP) and those for both strengthening Pi and dissolving phlegm (CD-SPDP) in inhibiting obesity. Excepting eight rats allocated in the blank control group
the other 54 rats were fed with high-lipid forage for 12 weeks to establish models of obesity. Finally
30 DIO rats and 8 DIO-R rats (shown by their body weight) were obtained. The DIO rats were divided into three groups
which were given gastric perfusion
respectively
with normal saline (Group A)
CD-SP (Group B)
and CD-SPDP (Group C). Fourteen weeks later
the animals’ body weight (BW)
length (BL)
blood levels of fasting insulin (FIn)
fasting glucose (FBG)
triglyceride (TG)
cholesterol (TC)
leptin (LP)
neuropeptide Y (NPY)
C-reactive protein (CRP)
tumor necrosis factor-α(TNF-α)
adiponectin (AN)
and resistin (RS) were measured; insulin resistance index (IRI) was calculated
and the degree of obesity and lipid content in abdominal cavity of rats were estimated. Moreover
the levels of LP
CRP
TNF-α
AN and RS in homogenate of rats’ adipose tissues (ATH) were determined. After 12 weeks of high-lipid diet
the BW of DIO rats was higher than that of normal or DIO-R rats. After a 14-week continuous high-lipid diet feeding
in DIO rats
BW
lipid coefficient (LC)
and IRI were significantly increased (P<0.01); serum levels of TNF-α
LP and AN were lower
NPY was higher
while the ATH levels of LP and AN were lower and TNF-α was higher in DIO rats than in DIO-R rats (P<0.05 or P<0.01); blood levels of FBG and lipids in DIO rats showed an increasing trend but was statistically insignificant (P>0.05); no significant difference was found in serum levels of CRP and RS due to the overly high data dispersion. Comparisons of the 3 DIO groups showed that BW
body weight index (BWI)
LC and IRI were significantly lowered after treatment (P<0.01) in Group C
while these indexes were not significantly different between Group A and B; the serum levels of TNF-α
LP
and AN increased
NPY decreased in Group B and C
ATH levels of LP and AN increased
and TNF-α decreased in the two groups; but NPY
LP
and AN in blood and ATH were higher in Group C than those in Group B (P<0.05 or P<0.01). CD-SPDP could inhibit DIO and IR
showing that the effect is better than that of CD-SP
and its mechanism is related to promotion of LP and AN secretion and elevation of serum NPY.
obesity antagonizinginsulin resistancestrengthening Pidissolving phlegmrat
obesity antagonizinginsulin resistancestrengthening Pidissolving phlegmrat
Levin BE, Joseph T, Susan Hogan. Metabolic features of diet-induced obesity without hyperphagia in yang rats. Am J Physiol 1986;251:Y433–440.
Levin BE, Triscari J, Hogan S, Sullivan AC. Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone and insulin. Am J Physiol 1987;252:471–478.
Hota misligil GS. Molecular mechanisms of insulinresistance and the role of the adipocyte. Int Jobes Relat Metab Disord 2000;24:S23
Pan YH, Xue YM. Obesity and insulin resistance. Guangdong Med J (Chin) 2005;26:270–271.
Chen MD. Products of adipocytes and obesity/metabolic syndrome. Chin J Endocrinol Metabol (Chin) 2003;19:161–163.
Qian BC. The principle and method for preparing the obesity animal model. Chin Pharmacol Bull (Chin) 1993;9:752–776.
Li Y, Wang BZ, Qi CX, Jiao LB, Cao L, Shen XH. A new method of preparing the obesity rat model. J Hebei Med Univ (Chin) 2005;26:305–308.
Shi WY, Yao XJ, Dong DN, Liu L, Bai YL, Xu JF, et al. Study on levels of serum TNF-α in diet-induced obese rats. China Public Health (Chin) 2002;18:573–574.
Kraegen EW, Clark PW, Jenkins AB, Daley WA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40:1397–1403.
Liang XZ, Zhang DF. Advances in research into relationship between adiponectin and coronary heart disease. Advances Cardiovasc Dis (Chin) 2007;28:940–944.
Cao L, Ma J. The Effect of Adiponectin in the Insulin Resistance. Forei Med Sci (Sec Hygiene, Chin) 2007;34:301–304.
Fang X, Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans 2006;34:798–801.
Li JQ, Li PC. The adiponectin and the vasculitis disease. Advances Cardiovasc Dis (Chin) 2004;25:317–318.
Cheng H. Obesity, metabolism symptom and inflammation. Forei Med Sci (Sec Endoc) 2004,24:151–153.
Steppan CM, Bailey ST, Bhat S, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307–312.
Yang G, Li L, Fang C, Zhang L, Li Q, Tang Y, et al. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats. Metabolism 2005;54:1142–1146.
Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252–11256.
Gu N, Guo XR, Chen RH. Resist in obesity and type 2 diabetes. Med Recapitul (Chin) 2006;12:159–161.
Nagaev l, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. J Biochem Biophys Res Commun 2001;285:561–564.
Liu LM, Ye GS, Ye GJ. Experimental study of dietary obesity in rat induced by high fat diet. J Peking Univ (Health Sci, Chin) 1991;23:359–361.
Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in the rats. Diabetes1991;40:B280–289.
Xue CY, Zheng ZX, Zhang RX, Zhang XP, Li XY, Inoue SJ, et al. A study on mechanism of high fat and sucrose diets in obesity development in rats. Acta Nutrimenta Sin (Chin) 1998;21:B42–46.
Xu SY, Bian RL, Chen X. Pharmacoempirical methodology. Beijing: People’s Medical Publishing House, 1982:781.
0
Views
359
Downloads
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621